Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease (Q34473820)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

title

Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

main subject

Alzheimer's disease

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

author

Joanna Picot

series ordinal

2

object named as

Joanna Picot

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

Emma Loveman

series ordinal

3

object named as

Emma Loveman

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

author name string

Colin Green

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

Andrea Takeda

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

Jo Kirby

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

Andrew Clegg

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

publication date

1 January 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

published in

PharmacoEconomics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

page(s)

1271-1282

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

cites work

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200523120-00010

retrieved

21 January 2018

The Mini-Mental State Examination: A Comprehensive Review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200523120-00010

retrieved

21 January 2018

A controlled study of survival with dementia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200523120-00010

retrieved

21 January 2018

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200523120-00010

retrieved

21 January 2018

Rate of cognitive decline and mortality in Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200523120-00010

retrieved

21 January 2018

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residential and nursing home care of elderly people with cognitive impairment: prevalence, mortality and costs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive deficits in Alzheimer's disease: treatment with acetylcholinesterase inhibitor agents.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and cognitive disability: modelling the underlying associations.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling mini mental state examination changes in Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil therapy in clinical practice: a randomized crossover study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should the Mini Mental State Examination be used to monitor dementia treatments?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine for Alzheimer's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting time to nursing home care and death in individuals with Alzheimer disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional Transitions and Active Life Expectancy Associated With Alzheimer Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The validity of using the mini mental state examination in NICE dementia guidelines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease: the burden of the illness in England.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of general practitioners in the diagnosis and treatment of Alzheimer's disease: a multinational survey.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of donepezil treatment for Alzheimer's disease in Japan

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the relationship between disease progression and cost of care in dementia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic and social cost of dementia in Ireland

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16336020

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00019053-200523120-00010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

Dimensions Publication ID

1036919276

0 references

PubMed publication ID

16336020

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16336020

retrieved

2 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34473820&oldid=2196675704"